GRIFOLS 19/27 REGSGRIFOLS 19/27 REGSGRIFOLS 19/27 REGS

GRIFOLS 19/27 REGS

No trades
See on Supercharts

Key terms


Outstanding amount
‪739.60 M‬EUR
Face value
1,000.00EUR
Minimum denomination
100,000.00EUR
Coupon
2.25% (Fixed)
Coupon frequency
Semi-annual
Yield to maturity
3.58%
Maturity date
Nov 15, 2027
Term to maturity
3 years

About GRIFOLS 19/27 REGS


Sector
Health Technology
Home page
Issue date
Nov 15, 2019
ISIN
XS2077646391
Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital Segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.
Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.